Organizer: UNODC Laboratory and Scientific Service Co-sponsors: Canada & United States of America Co-sponsors: Canada & United States of America Moderator: Mr. Jean-Luc Lemahieu, Director, Division of Policy Analysis and Public Affairs, UNODC Summary: The global synthetic drug problem is complex requiring dynamic and comprehensive strategies supported by interagency and international cooperation. Join us to learn …
World Health Organisation (WHO)
The Inequalities that Drive the HIV/AIDS Epidemic Among People Who Use Drugs and People in Prisons
Moderator: Monica Ciupagea Expert, Drug use and HIV, UNODC: Welcome to all, thank you for joining us for this side event. Fariba Soltani, Chief of HIV/AIDS Section, Global HIV Coordinator, UNODC will be opening, thank you Fariba. Speaker: Fariba Soltani Chief of HIV/AIDS Section, Global HIV Coordinator, UNODC: Thank you very much to all who …
Side Event: #Leaving No One Behind: Addressing Substance Use in Humanitarian Settings – Providing Access to Services for Displaced Populations and Host Communities in Acute and Protracted Emergencies
#Leaving No One Behind: Addressing Substance Use in Humanitarian Settings – Providing Access to Services for Displaced Populations and Host Communities in Acute and Protracted Emergencies Moderator: UNODC, Giovanna Campello, Chief of Prevention, Treatment, and Rehabilitation Section Speakers: Anja Busse, UNODC, Program Officer in Prevention, Treatment, and Rehabilitation Section Dr. Dzmitry Krupchanka, WHO, Medical Officer, …
Side event: Access to Controlled Medicines During COVID-19: meeting the needs of patients around the world
Organized by Belgium with the support of Australia, Canada, El Salvador, France, Lithuania, the Russian Federation, Switzerland and the United Kingdom, and the UNODC Prevention, Treatment and Rehabilitation Section, the International Association of Hospice and Palliative Care, the International Narcotics Control Board, the Union for Cancer Control, the Vienna NGO Committee on Drugs and the …
Plenary – Item 5. Implementation of the international drug control treaties (continued)
Chair: Good Morning Delegates. We will resume on item 5 (a) Secretariat: documents have been prepared under 5(a).. available now on commission’s website Chair: Proceed to WHO scheduling recommendations on substances under 1961 and 1971 Convention communicated after 63rd meeting of Expert Committee on Drug Dependence. We will now vote on isotonitazene to add to schedule I …
Side Event: Human Rights in Action: Implementing the International Guidelines on Human Rights and Drug Policy
Organized by the Office of the High-Commissioner for Human Rights with the support of Canada, Germany, the Netherlands, Norway, Malta, Mexico, Portugal, Switzerland, the United Kingdom and Uruguay, and the Council of Europe, the European Union, the International Centre on Human Rights and Drug Policy, the United Nations Development Programme and the World Health Organization …